標(biāo)題: Titlebook: Alternate Methods in the Treatment of Benign Prostatic Hyperplasia; Nicholas A. Romas,E. Darracott Vaughan Book 1993 Springer-Verlag Berli [打印本頁] 作者: HEIR 時(shí)間: 2025-3-21 17:24
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia影響因子(影響力)
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia影響因子(影響力)學(xué)科排名
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia網(wǎng)絡(luò)公開度
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia被引頻次
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia被引頻次學(xué)科排名
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia年度引用
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia年度引用學(xué)科排名
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia讀者反饋
書目名稱Alternate Methods in the Treatment of Benign Prostatic Hyperplasia讀者反饋學(xué)科排名
作者: HAWK 時(shí)間: 2025-3-21 22:43 作者: 云狀 時(shí)間: 2025-3-22 00:41
,Finasteride: A 5α-Reductase Inhibitor,and the observation that men with the genetic syndrome of 5α-R deficiency (male pseudohermaphrodites, MPHs) have atrophic prostate glands throughout their lives (Imperato-McGinley et al. 1974; Walsh et al. 1974).作者: 牽連 時(shí)間: 2025-3-22 06:21 作者: Projection 時(shí)間: 2025-3-22 08:59
mia, laser therapy, and prostatic stents are described. Medical treatment with alpha-blockers, 5 alpha-reductase inhibitors, and flutamide are addressed by authors who have had extensive clinical experience with the use of these agents.978-3-642-45725-8978-3-642-45723-4作者: 在駕駛 時(shí)間: 2025-3-22 13:31 作者: agnostic 時(shí)間: 2025-3-22 17:07 作者: ensemble 時(shí)間: 2025-3-22 21:14
Management of Fallopian Tube’s Obstructionsasic urologic management of prostate obstruction. Therefore, it is not surprising that there has been considerable enthusiasm, as well as early encouraging results, in the use of prostate endoprostheses.作者: Tartar 時(shí)間: 2025-3-23 01:46 作者: Impugn 時(shí)間: 2025-3-23 09:03 作者: 急性 時(shí)間: 2025-3-23 10:42
Prostate Urethral Prostheses,asic urologic management of prostate obstruction. Therefore, it is not surprising that there has been considerable enthusiasm, as well as early encouraging results, in the use of prostate endoprostheses.作者: inundate 時(shí)間: 2025-3-23 15:21 作者: 癡呆 時(shí)間: 2025-3-23 22:00
https://doi.org/10.1007/978-3-031-11910-1number of transurethral prostatectomies (TURPs) performed annually climbs over 500000, the potential for unnecessary or inadequate surgical procedures continues to rise at an alarming rate. Therefore, an accurate understanding of the mechanism responsible for BPH symptoms is essential for the appropriate management of the voiding dysfunction.作者: CURL 時(shí)間: 2025-3-24 01:17
Percutaneous Ablation of Uterine Myomastatome, incisor, excisor, prostatolithotrite, and kiotome. In spite of the refinement of this blind transurethral prostatic surgery at that time, this procedure never became widely accepted, primarily due to the high incidence of infection, bleeding, incontinence, and operative mortality.作者: Irrigate 時(shí)間: 2025-3-24 04:17
Urodynamic Assessment of Benign Prostatic Hypertrophy,number of transurethral prostatectomies (TURPs) performed annually climbs over 500000, the potential for unnecessary or inadequate surgical procedures continues to rise at an alarming rate. Therefore, an accurate understanding of the mechanism responsible for BPH symptoms is essential for the appropriate management of the voiding dysfunction.作者: SYN 時(shí)間: 2025-3-24 07:44 作者: Collision 時(shí)間: 2025-3-24 12:00 作者: 使腐爛 時(shí)間: 2025-3-24 18:28
Mandible, Teeth and Temporomandibular Jointsdards of care, practice parameters, etc. The simplest method of guideline development, whether it involves individuals or groups, requires experts to process in their heads all the important information and requires anybody using this guideline to take the experts’ opinion on faith.作者: Oversee 時(shí)間: 2025-3-24 22:28 作者: travail 時(shí)間: 2025-3-25 00:40 作者: 喪失 時(shí)間: 2025-3-25 06:17
Alternate Methods in the Treatment of Benign Prostatic Hyperplasia作者: opalescence 時(shí)間: 2025-3-25 10:59 作者: Headstrong 時(shí)間: 2025-3-25 12:40
Pathogenesis of Benign Prostatic Hyperplasia,d evaluation in 37% of 1071 Japanese males over the age of 55. Glynn and associates (1985) observed that 78% of 2049 healthy men in a longitudinal Veterans Administration study had a diagnosis of BPH on symptomatic or physical evaluation by the age of 80. The discordance in autopsy and clinical data作者: HALL 時(shí)間: 2025-3-25 16:34
Assessing Treatment Results for Benign Prostatic Hyperplasia, probably be incomplete by the time of publication of this volume. Lest one think this is a “pie in the sky” list, only two of these options (growth factor inhibitor and pyrotherapy) could be listed as laboratory, experimental, or theoretical considerations, while the rest are in fact real and avail作者: diabetes 時(shí)間: 2025-3-25 20:48 作者: infarct 時(shí)間: 2025-3-26 03:33
Diagnostic and Interventional Radiologyd evaluation in 37% of 1071 Japanese males over the age of 55. Glynn and associates (1985) observed that 78% of 2049 healthy men in a longitudinal Veterans Administration study had a diagnosis of BPH on symptomatic or physical evaluation by the age of 80. The discordance in autopsy and clinical data作者: Nomadic 時(shí)間: 2025-3-26 05:53
Radiation Biology and Radiation Protection probably be incomplete by the time of publication of this volume. Lest one think this is a “pie in the sky” list, only two of these options (growth factor inhibitor and pyrotherapy) could be listed as laboratory, experimental, or theoretical considerations, while the rest are in fact real and avail作者: 無節(jié)奏 時(shí)間: 2025-3-26 11:44
https://doi.org/10.1007/978-3-031-11910-1temperatures of 42°–43.5°C. This temperature range has been adopted by some of the current devices to treat BPH, and the use of the term “hyperthermia” is thus restricted to define those treatments which developed directly from cancer therapy and which heat to <44°C. Hyperthermia treatments for BPH 作者: Anal-Canal 時(shí)間: 2025-3-26 15:50
Conventional Diagnostic Radiologyisorder in men over 50 years of age and accounts for 1.7 million physician office visits and nearly 400 000 prostatectomies annually in the United States, few natural history studies of BPH have been conducted (Barry 1990a, b). Many urologists have probably followed more untreated BPH patients in th作者: floaters 時(shí)間: 2025-3-26 19:03 作者: Minikin 時(shí)間: 2025-3-27 00:52
Mandible, Teeth and Temporomandibular Jointsf the experts, algorithms, and decision trees, etc. These guidelines have identified practices that are considered to be standard and acceptable which in turn, were determined by whatever practices were in common use at the particular time. Guidelines have been referred to as practice policies, stan作者: Mnemonics 時(shí)間: 2025-3-27 04:43 作者: 使成波狀 時(shí)間: 2025-3-27 05:18
https://doi.org/10.1007/978-3-031-11910-1atients presenting with moderate symptoms of prostatism who are surgically treated will show symptomatic improvement (Lepor and Gilbert 1990). A recent study, which estimates that as many as 25% of prostatectomy patients may actually be unobstructed (Sch?fer et al. 1988), underscores the value of an作者: noxious 時(shí)間: 2025-3-27 09:48 作者: Flatus 時(shí)間: 2025-3-27 15:09 作者: FOIL 時(shí)間: 2025-3-27 20:05
https://doi.org/10.1007/978-3-031-11910-1hnique aims to provide relief to obstructed patients in an outpatient setting with minimal anesthesia. The term “hyperthermia” has become associated with the current trend for heat treatment of the prostate, but it has its origin in the treatment of malignant tissue. Indeed, the initial experience w作者: 娘娘腔 時(shí)間: 2025-3-27 22:08
R. F. Wolf MD,M. J. H. Slooff MD and laser energy can destroy prostate tissue while producing hemostasis. Because perioperative bleeding is the major cause of morbidity associated with prostatectomy, a technique that minimizes or eliminates bleeding could reduce morbidity, hospitalization, and costs and, therefore, improve outcome作者: 序曲 時(shí)間: 2025-3-28 05:06 作者: 嫻熟 時(shí)間: 2025-3-28 07:05 作者: Immunization 時(shí)間: 2025-3-28 12:46
R. F. Wolf MD,M. J. H. Slooff MD enzyme 5α-reductase (5α-R). DHT is currently regarded as the most important factor in the pathogenesis of benign prostatic hyperplasia (BPH). This is based on experimental data showing that DHT is by far the most abundant androgenic hormone within prostatic cell nuclei (Bruchovsky and Wilson 1968) 作者: Plaque 時(shí)間: 2025-3-28 15:47
Radiological Imaging of the Living Donorluence of either androgens or estrogens remains unresolved, there is ample evidence to support their pharmacologic manipulation in the treatment of BPH. Hormonal regulation of BPH can be initiated by one of several approaches:.This chapter will discuss the use of flutamide, an antiandrogen, and aromatase inhibitors in BPH.作者: 不法行為 時(shí)間: 2025-3-28 21:32
Flutamide and Aromatase Inhibitors in Benign Prostatic Hypertrophy,luence of either androgens or estrogens remains unresolved, there is ample evidence to support their pharmacologic manipulation in the treatment of BPH. Hormonal regulation of BPH can be initiated by one of several approaches:.This chapter will discuss the use of flutamide, an antiandrogen, and aromatase inhibitors in BPH.作者: Gossamer 時(shí)間: 2025-3-29 02:52
https://doi.org/10.1007/978-3-642-45723-4Laser; Prostataerkrankung; Prostatahyperplasie; Urologie; balloon dilatation of the prostate; benign pros作者: omnibus 時(shí)間: 2025-3-29 04:11
978-3-642-45725-8Springer-Verlag Berlin Heidelberg 1993作者: 人類 時(shí)間: 2025-3-29 10:42
http://image.papertrans.cn/a/image/154016.jpg作者: Resistance 時(shí)間: 2025-3-29 15:02
